Yankees manager Aaron Boone revealed Thursday that Volpe has been playing through a partial labrum tear in his left shoulder, Bryan Hoch of MLB.com reports.

Volpe underwent an MRI in May after hurting his left shoulder on a dive. The imaging revealed a tear, though the Yankees believed it was an old injury that the shortstop could play through. Volpe has done just that, avoiding a stint on the injured list, but his play has suffered, as he's struggled defensively and slashed .182/.230/.368 since June 1. The 24-year-old has aggravated the injury a few times this season, including this past weekend, resulting in him receiving a cortisone injection Wednesday. Volpe is out of the lineup for a second straight day Thursday, but the organization doesn't think he'll require a trip to the IL. Jose Caballero is handling shortstop again for the Yanks on Thursday and could share the job with Volpe down the stretch, if not take the gig outright. Volpe will likely undergo another MRI on his shoulder after the season to check on how it has healed. To this point, it does not seem that surgery has been discussed.

Volpe (shoulder) isn't in the lineup for Thursday's game against the Tigers.

Volpe recently received a cortisone shot in his left shoulder to treat the shoulder injury that has been bothering him since May, so it isn't too surprising to see him heading to the bench for the start of Thursday's contest. Jose Caballero will start at shortstop in Volpe's place and bat eighth.

Celesten is hitting .158 with one home run, one steal and 15 strikeouts in 11 games for High-A Everett.

Celesten, who was promoted from Single-A Modesto on Aug. 18, has an 18.8 percent walk rate and 31.3 percent strikeout rate in this tiny sample, in part because he's been more passive (48.8 percent swing rate at Single-A, 39.3 percent swing rate at High-A). Believed to have plus speed and plus power potential when he signed for $4.7 million as the headliner of the 2023 international signing class, Celesten's power has been mostly dormant, as he slashed .285/.349/.384 with five home runs and 20 steals in 93 games prior to his promotion to High-A. There is post-hype breakout potential with Celesten in 2026, but injuries earlier in his career have led to him no longer being young for his levels, so there will also be pressure on the switch-hitting shortstop to perform in his age-20 season.

Genao is slashing .251/.319/.354 with two home runs, six steals and a 16.4 percent strikeout rate in 73 games for Double-A Akron.

A sprained right shoulder sidelined Genao until June, and it's possible the shoulder issue sapped some power, although it's worth noting he homered three times in eight complex-league rehab games, so it could also be facing Double-A pitching for the first time that has stymied his offensive impact. The 21-year-old switch hitter has only played shortstop this season and his defensive abilities will put less pressure on his bat, but he'll still need to hit for more power than he has this year at Double-A. Genao, who reportedly grew an inch and added muscle this past offseason, stole 25 bases in 110 games last year but has six swipes in 81 games this year.

Nimmala is slashing .224/.313/.381 with 13 home runs and 17 steals in 120 games for High-A Vancouver.

Nimmala has a .566 OPS over his last 79 games after starting the year with a .917 OPS in his first 41 games. While he will finish the year as a below-average hitter (91 wRC+) in the Northwest League, Nimmala is the youngest qualified player in the league and fourth-youngest qualified hitter at High-A, so he should be graded on a bit of a curve. The power-hitting shortstop finished 2024 on fire (.888 OPS over his final 55 games) but it's the opposite trend to close 2025. That said, he cut his strikeout rate from 30.7 percent in 2024 to 21.4 percent in 2025 while keeping his walk rate steady at 10 percent. Nimmala's stock is down after this summer-long slump, but he still has a chance to be Toronto's shortstop of the future. The only other players 19 and under to hit 13-plus home runs with double-digit steals and a strikeout rate under 25 percent this season are Konnor Griffin, Eduardo Quintero, Edward Florentino, Sebastian Walcott and Colt Emerson.

Volpe was given a cortisone shot in his left shoulder for an injury he suffered in early May, Joel Sherman of the New York Post reports.

Volpe described feeling a "pop" in his shoulder when he dived for a ball during a May 3 game against the Rays. He was cleared of structural damage and never went on the injured list, but Volpe has had "discomfort on occasion in the area since," per Sherman. The injury could at least partly explain Volpe's poor performance, as he has slashed .197/.248/.378 since and has struggled defensively. Jose Caballero started at shortstop for the Yankees on Wednesday, and manager Aaron Boone has indicated his starter at the position moving forward is fluid. It's not clear whether Volpe was available off the bench Wednesday or will be Thursday, as players who receive cortisone shots typically don't play for at least a couple days.

Walcott is slashing .338/.456/.473 with two home runs, eight steals, a 16.7 percent walk rate and an 11.1 percent strikeout rate in his last 74 at-bats for Double-A Frisco.

The pitching at Double-A is pretty watered down at this time of year, but it's still notable that Walcott is closing the year strong after he slumped for a couple months from mid-June through mid-August, when he logged a .581 OPS. On the year, the toolsy Bahamian infielder is slashing .251/.353/.386 with 13 home runs, 32 steals, a 12.9 percent walk rate and a 19.8 percent strikeout rate in 120 games as easily the youngest qualified hitter at Double-A -- Nelson Rada is the second-youngest qualified hitter at Double-A and he's almost seven months older than Walcott. It was announced this week that Walcott will play in the Arizona Fall League this year, which should set the stage for a big-league debut sometime next summer. Walcott has started 17 games at third base and 82 games at shortstop this year.

Rocchio started at shortstop and went 2-for-3 with a walk in Wednesday's 4-3 win over the Royals.

Rocchio made a second consecutive start at shortstop with Gabriel Arias nursing a wrist injury. Arias will play through the injury while the Guardians compete for a playoff spot, but it's unclear what level of activity he can tolerate. Rocchio, who has been the primary second baseman, may see more action at shortstop going forward. His season numbers are negatively skewed by an unproductive first two months (.530 OPS), which prompted a demotion to the minors. Since returning to the majors July 1, Rocchio's been much better, slashing .276/.330/.412 over 63 games.

Arias (wrist) will play through his injury while the Guardians continue a push for a postseason spot, Tim Stebbins of MLB.com reports.

Arias consulted with the team's medical staff and hand specialist Dr. Thomas Graham, and it was determined he could play through the issue. Arias initially injured the wrist in a win over the Mariners on Aug. 29 and aggravated the issue Monday. He's sat the two games since with Brayan Rocchio filling in at shortstop.

Correa went 2-for-4 with a solo home run in Wednesday's 3-2 win over Toronto.

Correa blasted his 13th homer of the season and the 200th of his excellent career. The slugging infielder now has at least one hit in eight of his first nine outings in September. Correa had a middling .705 OPS for the Twins this year, but he's slashing .297/.354/.455 with six long balls, five doubles, 19 RBI and 18 runs scored over 158 plate appearances for the Astros to improve his OPS to .737 for the campaign.